Top Markets
Coin of the day
Molecure S.A. Molecure S.A.

Molecure S.A.

MOC
Rank in Stocks #26168
Operating as a biopharmaceutical firm in Poland, Molecure S.A. specializes in... Operating as a biopharmaceutical firm in Poland, Molecure S.A. specializes in the research, development, and commercialization of innovative therapies designed to combat neoplastic (cancer) and inflammatory conditions. The company's pipeline prominently features OATD-01, a chitotriosidase/acidic mammalian chitinase inhibitor that has successfully advanced through Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis and sarcoidosis. Additionally, Molecure is progressing its YKL-40 program for cancer and fibrosis, OATD-02 for oncology applications, and a Deubiquitinase program. Established in 2012, this Warsaw-headquartered enterprise adopted the name Molecure S.A. in March 2022, having previously been known as OncoArendi Therapeutics S.A.
Share Price
$1.73
Market Cap
$42.88M
Change (1 day)
2.16%
Change (1 year)
-18.85%
Country
PL
Trade Molecure S.A. (MOC)

Category

Stock price history for Molecure S.A. (MOC)
Highest end of day price: $1.72 on 2026-08-01

Lowest end of day price: $8.01 on 2018-04-01
Stock price history of Molecure S.A. from 2018 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -4.92%
2025 -23.76%
2024 -51.57%
2023 52.92%
2022 -63.44%
2021 -31.76%
2020 420.16%
2019 -41.51%
2018 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$539.78 36.87%
US
$1.04K 56.66%
NL
$120.74 -14.98%
AU
$761.87 7.04%
CH
$133.79 397.56%
US